RPS4XP13: A Potential Drug Target and Biomarker for Ribosomal Protein S4X

Target Name: RPS4XP13

NCBI ID: G390183

RPS4XP13

Other Name(s): Ribosomal protein S4X pseudogene 13 | ribosomal protein S4X pseudogene 13 | RPS4P13 | RPS4X_3_1145

RPS4XP13: A Potential Drug Target and Biomarker for Ribosomal Protein S4X

Ribosomal protein S4X pseudogene 13 (RPS4XP13) is a protein that is expressed in various cell types, including muscle, heart, and brain, and plays a critical role in cell signaling and metabolism. The protein is composed of 13 amino acids and has a calculated molecular weight of 18 kDa. Despite its importance, little is known about RPS4XP13, including its function and potential as a drug target or biomarker.

In this article, we will explore the potential implications of RPS4XP13 as a drug target and biomarker. We will discuss the current understanding of the protein's function, its potential targets, and the research being conducted to investigate its potential as a drug.

Function and Potential Targets

Ribosomal protein S4X pseudogene 13 is involved in various cellular processes, including protein synthesis, cell signaling, and DNA replication. It is a key component of the ribosome, which is the protein machine that synthesizes proteins in the cell. The protein interacts with the rRNA subunit and is involved in the formation of the ribosome dimer, as well as the loading of amino acids onto the A-site for protein synthesis.

Several studies have suggested that RPS4XP13 may be a potential drug target due to its unique structure and the involvement in cellular processes that are often disrupted in diseases such as cancer, neurodegenerative diseases, and metabolic disorders. RPS4XP13 has been shown to play a role in the development and progression of various diseases, including cancer, neurodegenerative diseases, and metabolic disorders.

One potential target for RPS4XP13 is the protein p21, which is a well-established cancer suppressor protein that is often expressed in high levels in cancer cells. Studies have shown that RPS4XP13 can interact with p21 and may inhibit its activity, leading to the loss of cell proliferation and survival in cancer cells. This interaction between RPS4XP13 and p21 makes RPS4XP13 a potential drug target for cancer treatment.

Another potential target for RPS4XP13 is the protein HSP70, which is a heat- shock protein that plays a critical role in stress response and DNA damage repair. Studies have shown that RPS4XP13 can interact with HSP70 and may influence its activity, leading to changes in cellular behavior and metabolism. This interaction between RPS4XP13 and HSP70 makes RPS4XP13 a potential drug target for diseases that are characterized by oxidative stress, such as neurodegenerative diseases and cancer.

Potential Biomarkers

RPS4XP13 has the potential to serve as a biomarker for various diseases due to its unique expression and involvement in cellular processes that are often disrupted in these diseases. One potential biomarker for RPS4XP13 is its expression level, which can be used to monitor disease progression and response to treatment.

Another potential biomarker for RPS4XP13 is its function in cellular signaling, which can be used to monitor the impact of drugs on cellular behavior and metabolism. Studies have shown that RPS4XP13 plays a critical role in cell signaling and that its function can be modulated by various factors, including drugs. This makes RPS4XP13 a potential biomarker for diseases that are characterized by cellular dysfunction and signaling disorders, such as neurodegenerative diseases and cancer.

Conclusion

Ribosomal protein S4X pseudogene 13 (RPS4XP13) is a protein that is involved in various cellular processes and has been shown to play a critical role in the development and progression of various diseases. Its unique structure and involvement in cellular processes make it a potential drug target and biomarker for diseases that are characterized by cellular dysfunction and signaling disorders. Further research is needed to fully understand the function and potential of RPS4XP13 as a drug target and biomarker.

Protein Name: Ribosomal Protein S4X Pseudogene 13

The "RPS4XP13 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RPS4XP13 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets